Sign In
Buy VTRS
$17.56
-0.200 (-1.13%)
At Close: Jul 31, 2026
Viatris Inc. (VTRS) Q1 2026 Earnings Call Transcript
02:21pm, Thursday, 07'th May 2026
Viatris Inc. (VTRS) Q1 2026 Earnings Call Transcript
Viatris beats quarterly estimates on China strength, branded drug sales
12:30pm, Thursday, 07'th May 2026
Viatris topped analysts' estimates for first-quarter revenue and profit on Thursday, buoyed by strength in its China business and strong demand for branded drugs.
Here's What Key Metrics Tell Us About Viatris (VTRS) Q1 Earnings
10:31am, Thursday, 07'th May 2026
While the top- and bottom-line numbers for Viatris (VTRS) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare t
Viatris (VTRS) Q1 Earnings and Revenues Surpass Estimates
09:55am, Thursday, 07'th May 2026
Viatris (VTRS) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $0.5 per share a year ago.
Viatris Reports First-Quarter 2026 Financial Results
06:59am, Thursday, 07'th May 2026
Delivers Total Revenues of $3.5 Billion, Representing 8% Reported Growth Compared to First Quarter 2025, and U.S. GAAP Net Earnings of $176 Million Total Revenues Were Up 3% Operationally Compared to
Exploring Analyst Estimates for Viatris (VTRS) Q1 Earnings, Beyond Revenue and EPS
10:15am, Wednesday, 06'th May 2026
Beyond analysts' top-and-bottom-line estimates for Viatris (VTRS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter
Viatris Gears Up to Report Q1 Earnings: What's in the Cards?
02:20pm, Tuesday, 05'th May 2026
VTRS gears up to report Q1 results as import alerts, regional pressures and growth in key brands shape expectations ahead of May 7 release.
Viatris Announces Quarterly Dividend
06:59am, Tuesday, 05'th May 2026
PITTSBURGH, May 5, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) today announced that on May 4, 2026, its Board of Directors declared a quarterly dividend of $0.12 per share for each issued and ou
Viatris Announces Chief Financial Officer Transition
04:30pm, Monday, 04'th May 2026
Theodora "Doretta" Mistras to Depart; Paul Campbell Named Interim CFO PITTSBURGH, May 4, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that Theodora "D
PITTSBURGH, May 1, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that six abstracts on its investigational low-dose estrogen combined hormonal contrac
Viatris (VTRS) Earnings Expected to Grow: Should You Buy?
11:01am, Thursday, 30'th Apr 2026
Viatris (VTRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Viatris to Report First Quarter 2026 Financial Results on May 7, 2026
06:59am, Monday, 13'th Apr 2026
PITTSBURGH, April 13, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced it will report first quarter 2026 financial results on Thursday, May 7, 2026. Compa
Viatris Announces Multiple Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting
06:59am, Friday, 10'th Apr 2026
PITTSBURGH, April 10, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that four abstracts will be presented at the American Society of Cataract and Refra
Viatris Inc. (VTRS) Discusses Long-Term Growth Outlook and Portfolio Strategy Across Generics, Established Brands and Innovative Medicines Transcript
Viatris Advances Innovative Portfolio with Approval of Effexor® in Japan for Adults with Generalized Anxiety Disorder (GAD)
06:59am, Monday, 23'rd Mar 2026
Addresses a Significant Unmet Need in Japan as First and Only Approved Treatment Option for GAD PITTSBURGH, March 23, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, to
